A rating of 45 puts Context Therapeutics Inc (CNTX) near the middle of the Biotechnology industry according to InvestorsObserver. Context Therapeutics Inc's score of 45 means it scores higher than 45% of stocks in the industry. Context Therapeutics Inc also received an overall rating of 50, putting it above 50% of all stocks. Biotechnology is ranked 16 out of the 148 industries.
CNTX has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on CNTX!